CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 100.0%

Compliant submissions 2

Incompliant submissions 0

Total trials 2

My Organizations' Clinical Trials

Showing 700 of 2003 entries

View as:

Tele-yoga Program in COPD and Heart Failure

Phase: N/A Priority: Normal

NCT ID: NCT02078739 Org: User:

Start: 06/30/13 End: 12/31/14 Due: 12/31/15

Predictors of Outcomes in MBSR Participants From Teacher Factors

Phase: N/A Priority: Normal

NCT ID: NCT03384771 Org: User:

Start: 01/11/17 End: 01/26/20 Due: 01/26/21

Microbiota Intervention to Change the Response of Parkinson's Disease

Phase: N/A Priority: Normal

NCT ID: NCT03575195 Org: User:

Start: 07/15/19 End: 06/30/25 Due: 06/30/26

Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry

Phase: N/A Priority: Normal

NCT ID: NCT02100904 Org: User:

Start: 05/31/14 End: 09/30/25 Due: 09/30/26

Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM)

Phase: N/A Priority: Normal

NCT ID: NCT02330419 Org: User:

Start: 04/30/15 End: 01/31/21 Due: 01/31/22

Evaluating the Role of Inflammation in Neonatal Epileptogenesis

Phase: N/A Priority: Normal

NCT ID: NCT04259125 Org: User:

Start: 12/15/18 End: 09/01/25 Due: 09/01/26

Trachoma Elimination Follow-up

Phase: N/A Priority: Normal

NCT ID: NCT00221364 Org: User:

Start: 03/31/03 End: 04/30/05 Due: 04/30/06

Implementing Pathways to Improve Pediatric Asthma Care

Phase: N/A Priority: Normal

NCT ID: NCT03736603 Org: User:

Start: 01/01/18 End: 06/30/19 Due: 06/30/20

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal

NCT ID: NCT06682442 Org: User:

Start: 03/18/25 End: 03/31/32 Due: 03/31/33

Symptom Management After Breast Cancer Surgery

Phase: N/A Priority: Normal

NCT ID: NCT00686127 Org: User:

Start: 09/30/03 End: 12/31/07 Due: 12/31/08

Using Clinical Decision Support to Provide Social Risk-Informed Care for Opioid Use Disorder in the Emergency Department

Phase: N/A Priority: Normal

NCT ID: NCT06872190 Org: User:

Start: 04/20/25 End: 07/31/27 Due: 07/31/28

Targeting High Risk Populations With Enhanced Reactive Case Detection in Southern Lao Peoples Democratic Republic

Phase: N/A Priority: Normal

NCT ID: NCT04416945 Org: User:

Start: 09/20/20 End: 11/01/21 Due: 11/01/22

Antioxidants for Prevention of Cataracts Follow-up Study

Phase: N/A Priority: Normal

NCT ID: NCT01664819 Org: User:

Start: 08/31/12 End: 08/31/13 Due: 08/31/14

Role of Positive Affect in Adjustment to HIV

Phase: N/A Priority: Normal

NCT ID: NCT00582023 Org: User:

Start: 09/30/04 End: 06/30/12 Due: 06/30/13

Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00303992 Org: User:

Start: 05/31/04 End: 01/31/13 Due: 01/31/14

Neonatal Seizure Registry - Developmental Functional EValuation

Phase: N/A Priority: Normal

NCT ID: NCT04337697 Org: User:

Start: 03/15/20 End: 03/01/25 Due: 03/01/26

Spatiotemporal Dynamics of the Human Emotion Network

Phase: N/A Priority: Normal

NCT ID: NCT05152992 Org: User:

Start: 04/20/15 End: 06/30/26 Due: 06/30/27

Comparing Intra-vaginal Culture of Embryos to In-vitro Culture of Embryos With Minimal Stimulation

Phase: N/A Priority: Normal

NCT ID: NCT02802176 Org: User:

Start: 10/31/16 End: 08/25/22 Due: 08/25/23

Metabolic Health Improvement Program: Effects of a Workplace Sugary Beverages Sales Ban and Motivational Counseling

Phase: N/A Priority: Normal

NCT ID: NCT05972109 Org: User:

Start: 08/01/23 End: 10/01/25 Due: 10/01/26

Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab

Phase: N/A Priority: Normal

NCT ID: NCT04407442 Org: User:

Start: 11/30/20 End: 04/30/23 Due: 04/30/24

Health eHeart BioBank

Phase: N/A Priority: Normal

NCT ID: NCT06976502 Org: User:

Start: 04/01/25 End: 12/31/35 Due: 12/31/36

Probiotic Administration for Adolescent Depression

Phase: N/A Priority: Normal

NCT ID: NCT06898788 Org: User:

Start: 05/15/25 End: 12/31/26 Due: 12/31/27

Dichoptic Virtual Reality Therapy for Amblyopia in Adults

Phase: N/A Priority: Normal

NCT ID: NCT02246556 Org: User:

Start: 10/31/14 End: 04/30/16 Due: 04/30/17

Subxyphoid Hybrid MAZE Registry for Patients With Persistent Atrial Fibrillation

Phase: N/A Priority: Normal

NCT ID: NCT04148625 Org: User:

Start: 09/14/16 End: 12/30/21 Due: 12/30/22

Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow

Phase: N/A Priority: Normal

NCT ID: NCT01825369 Org: User:

Start: 12/31/14 End: 07/31/20 Due: 07/31/21

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Tele-yoga Program in COPD and Heart Failure	NCT02078739	University of California, San Francisco	user2@example.com	None	2013-06-30	2014-12-31	2015-12-31	-	-	2025-07-14
Predictors of Outcomes in MBSR Participants From Teacher Factors	NCT03384771	University of California, San Francisco	user2@example.com	None	2017-01-11	2020-01-26	2021-01-26	-	-	2025-07-14
Microbiota Intervention to Change the Response of Parkinson's Disease	NCT03575195	University of California, San Francisco	user2@example.com	None	2019-07-15	2025-06-30	2026-06-30	-	-	2025-07-14
Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry	NCT02100904	University of California, San Francisco	user2@example.com	None	2014-05-31	2025-09-30	2026-09-30	-	-	2025-07-14
Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM)	NCT02330419	University of California, San Francisco	user2@example.com	None	2015-04-30	2021-01-31	2022-01-31	-	-	2025-07-14
Evaluating the Role of Inflammation in Neonatal Epileptogenesis	NCT04259125	University of California, San Francisco	user2@example.com	None	2018-12-15	2025-09-01	2026-09-01	-	-	2025-07-14
Trachoma Elimination Follow-up	NCT00221364	University of California, San Francisco	user2@example.com	None	2003-03-31	2005-04-30	2006-04-30	-	-	2025-07-14
Implementing Pathways to Improve Pediatric Asthma Care	NCT03736603	University of California, San Francisco	user2@example.com	None	2018-01-01	2019-06-30	2020-06-30	-	-	2025-07-14
Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma	NCT06682442	University of California, San Francisco	user2@example.com	None	2025-03-18	2032-03-31	2033-03-31	-	-	2025-07-14
Symptom Management After Breast Cancer Surgery	NCT00686127	University of California, San Francisco	user2@example.com	None	2003-09-30	2007-12-31	2008-12-31	-	-	2025-07-14
Using Clinical Decision Support to Provide Social Risk-Informed Care for Opioid Use Disorder in the Emergency Department	NCT06872190	University of California, San Francisco	user2@example.com	None	2025-04-20	2027-07-31	2028-07-31	-	-	2025-07-14
Targeting High Risk Populations With Enhanced Reactive Case Detection in Southern Lao Peoples Democratic Republic	NCT04416945	University of California, San Francisco	user2@example.com	None	2020-09-20	2021-11-01	2022-11-01	-	-	2025-07-14
Antioxidants for Prevention of Cataracts Follow-up Study	NCT01664819	University of California, San Francisco	user2@example.com	None	2012-08-31	2013-08-31	2014-08-31	-	-	2025-07-14
Role of Positive Affect in Adjustment to HIV	NCT00582023	University of California, San Francisco	user2@example.com	None	2004-09-30	2012-06-30	2013-06-30	-	-	2025-07-14
Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast Cancer	NCT00303992	University of California, San Francisco	user2@example.com	None	2004-05-31	2013-01-31	2014-01-31	-	-	2025-07-14
Neonatal Seizure Registry - Developmental Functional EValuation	NCT04337697	University of California, San Francisco	user2@example.com	None	2020-03-15	2025-03-01	2026-03-01	-	-	2025-07-14
Spatiotemporal Dynamics of the Human Emotion Network	NCT05152992	University of California, San Francisco	user2@example.com	None	2015-04-20	2026-06-30	2027-06-30	-	-	2025-07-14
Comparing Intra-vaginal Culture of Embryos to In-vitro Culture of Embryos With Minimal Stimulation	NCT02802176	University of California, San Francisco	user2@example.com	None	2016-10-31	2022-08-25	2023-08-25	-	-	2025-07-14
Metabolic Health Improvement Program: Effects of a Workplace Sugary Beverages Sales Ban and Motivational Counseling	NCT05972109	University of California, San Francisco	user2@example.com	None	2023-08-01	2025-10-01	2026-10-01	-	-	2025-07-14
Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab	NCT04407442	University of California, San Francisco	user2@example.com	None	2020-11-30	2023-04-30	2024-04-30	-	-	2025-07-14
Health eHeart BioBank	NCT06976502	University of California, San Francisco	user2@example.com	None	2025-04-01	2035-12-31	2036-12-31	-	-	2025-07-14
Probiotic Administration for Adolescent Depression	NCT06898788	University of California, San Francisco	user2@example.com	None	2025-05-15	2026-12-31	2027-12-31	-	-	2025-07-14
Dichoptic Virtual Reality Therapy for Amblyopia in Adults	NCT02246556	University of California, San Francisco	user2@example.com	None	2014-10-31	2016-04-30	2017-04-30	-	-	2025-07-14
Subxyphoid Hybrid MAZE Registry for Patients With Persistent Atrial Fibrillation	NCT04148625	University of California, San Francisco	user2@example.com	None	2016-09-14	2021-12-30	2022-12-30	-	-	2025-07-14
Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow	NCT01825369	University of California, San Francisco	user2@example.com	None	2014-12-31	2020-07-31	2021-07-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance